Comments
The board of directors of Dr Reddy’s Laboratories will meet on Wednesday to consider a buyback of shares. According to the shareholding pattern for the December quarter, public shareholding in the company was at 74.43 per cent or 9.40 crore shares, while promoter holding was at 25.57 per cent or 4.36 crore shares. The group posted a net profit of ₹579.2 crore in Q3FY16 on a topline of ₹3,980.1 crore against a net profit of ₹574.5 crore in Q3FY15 on a topline of ₹3,877.2 crore on consolidated basis.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.